Marlboro maker hits reset on $2B bet on medicine

By The Wall Street Journal
| September 20, 2023

Philip Morris considers selling stake in a recently acquired pharmaceutical business after setbacks.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

One of the most important elements of a company’s success is also one of the least tangible —culture. ...